Zymeworks
zymeworks.com
Actively hiring
Oncology Therapeutics
Biologics & Biosimilars
As featured in
View 4 jobs
Claim pageClaim
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
News
Zymeworks stock gains on fresh Wolfe Research coverage
Zymeworks stock is back on analysts' radar after Wolfe Research initiated coverage with an Outperform rating on September 17, 2026. Recent quarterly figures and the current valuation give investors a clearer view of the biotech's risk-reward profile.
Read more
Report
Zymeworks stock gains on merger approval and a $41 target
Zymeworks stock closed at USD 26.57 on September 18, 2026, with market value at USD 1.89 billion. MarketBeat cites a consensus target of USD 41.00 and Theravance merger approval on September 18, 2026.
Read more
Report
Report
Ziihera (zanidatamab-hrii) plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Versus Trastuzumab plus Chemotherapy in First-Line HER2+ Advanced GEA
The post Ziihera (zanidatamab-hrii) plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Versus Trastuzumab plus Chemotherapy in First-Line HER2+ Advanced GEA appeared first on Zymeworks.
Read more
Report
U.S. FDA Approves Ziihera (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma
The post U.S. FDA Approves Ziihera (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma appeared first on Zymeworks.
Read more
Report
Zymeworks Announces Participation in Upcoming Investor Conferences
The post Zymeworks Announces Participation in Upcoming Investor Conferences appeared first on Zymeworks.
Read more
Report
Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results
The post Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results appeared first on Zymeworks.
Read more
Report
Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Detailed price information for Zymeworks Inc (ZYME-Q) from The Globe and Mail including charting and trades.
Read more
Report
Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026
The post Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026 appeared first on Zymeworks.
Read more
Report
Show more news
Tech stack
Technologies named in job postings at Zymeworks over the last 12 months, by layer, with the share of postings for each.
Technologies in use
6
Postings analysed
3
Stack modernity
60/100
Developer tools
Model Context Protocol
Practices & domains
CAPA
ELISA
ETL/ELT
GMP
HPLC
Sign in to see how your skills match this stack
Sign In
People
Kenneth Galbraith
Executive Officer, Director
Gordon Ng
Executive Officer
David Tucker
Executive Officer
Neil Klompas
Executive Officer
Ali Tehrani
Executive Officer, Director
Surjit Dixit
Executive Officer
Jeffrey Smith
Executive Officer
Paul Moore
Executive Officer
Chris Astle
Executive Officer
Shermaine Tilley
Director
Dion Madsen
Director
Donald Drakeman
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
69/100
Growing
Open positions
4
1 opened / 1 closed in 30 days
Median time-to-fill
21 days
faster than 54% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Early Careers
43% ▼
Science & Research
29% ▲
HR
14% ▲
Industrial Engineering
14% ▲
Activity Timeline
New location: Swords
Sep 2026
Added Microsoft Office to stack
Sep 2026
Offices
Where the company hires and what each office is for
Cities
4
Hiring now
2
Countries
3
Busiest office
Vancouver
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Vancouver
Canada
HQ
Zymeworks Inc.
2 open roles 6 posted in 90 days 50% engineering 200-500 est. staff
hires for Science & Research, Solutions
114 East 4th Avenue, Suite 800, Vancouver, BC, Canada V5T 1G4
Bellevue
United States
2 open roles 1 posted in 90 days 50-200 est. staff
hires for Management, Industrial Engineering
Singapore
Singapore
Regional office
Zymeworks Lifesciences Pte. Ltd.
Science Park 1, 2 Science Park Drive, Singapore 112888
Bellevue
United States
Regional office
Zymeworks Biopharmaceuticals Inc
777 108th Ave NE, Suite 1700, Bellevue, WA, 98004
Earlier presence
Swords, Ireland
Jobs
≈ $142k – $275k per year (Estimated) • Equity • In office • Full-Time • 8+ years exp • Bachelor's Degree • Bellevue
GMP
MedTech
CAPA
Apply
≈ $46k – $89k per year (Estimated) • Equity • In office • Full-Time • 2+ years exp • Master's Degree • Vancouver
ELISA
HPLC
Apply
≈ $101k – $188k per year (Estimated) • Equity • In office • Full-Time • Bachelor's Degree • Bellevue
Apply
≈ $82k – $160k per year (Estimated) • Equity • In office • Full-Time • 8+ years exp • Vancouver
Model Context Protocol
Analytics
ETL/ELT
Management
SharePoint
Apply